RNU6-122P

RNA & survival
SurvivalRNAKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, RNU6-122P RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated RNU6-122P data layer.

The strongest signal is observed in kidney chromophobe (KICH), where higher RNU6-122P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6-122P expression acts as an unfavorable survival marker, although some lineages such as BLCA and OV show a favorable association.

KICH, BLCA, and UCEC are the cancer types where RNU6-122P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
KICHDFSTertileAll0.0430.971<.00148view →
BLCADFSTertileIV0.9310.248<.00148view →
UCECOSTertileIV0.2540.607.00736view →
KIRPOSTertileIII,IV0.4540.799.00733view →
LGGDFSTertileAll0.1960.475.00133view →
KIRCDFSQuartileAll0.4080.675.01524view →
DLBCOSTertileIII,IV0.1721.000.01418view →
OVOSQuartileII,III,IV0.7540.671.01212view →
READDFSTertileAll0.2500.625.0298view →
STADOSTertileIV0.9180.399.0496view →
ESCADFSMedianIII,IV0.4300.248.0256view →
HNSCOSTertileIII,IV0.7470.333.0356view →
Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

RNU6-122P–KICH (DFS)

Kaplan–Meier survival curve for RNU6-122P RNA-high vs -low samples in KICH.

Open the KICH breakdown →

Exploration